CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option exercise | +15,000 | $2.71 | $41K | 17,115 |
| 2024-06-11 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option exercise · Incentive Stock Option | −15,000 | 0 | ||
| 2024-06-07 | Crowley Elizabeth SR. VP & CPDO | Option exercise | +7,500 | $10.38 | $78K | 16,574 |
| 2024-06-07 | Crowley Elizabeth SR. VP & CPDO | Option exercise | +7,500 | $9.02 | $68K | 24,074 |
| 2024-06-07 | Crowley Elizabeth SR. VP & CPDO | Sale | −15,000 | $35.06 | $526K | 9,074 |
| 2024-06-07 | Crowley Elizabeth SR. VP & CPDO | Option exercise · Incentive Stock Option (Right to Buy) | −7,500 | 76,500 | ||
| 2024-06-07 | Crowley Elizabeth SR. VP & CPDO | Option exercise · Incentive Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2024-06-07 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Sale | −45,000 | $35.26 | $1.6M | 2,115 |
| 2024-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise | +9,540 | $10.38 | $99K | 35,464 |
| 2024-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise · Incentive Stock Option (Right to Buy) | −9,540 | 18,454 | ||
| 2024-06-03 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise | +6,289 | $9.02 | $57K | 13,383 |
| 2024-06-03 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise | +58,369 | $10.38 | $606K | 71,752 |
| 2024-06-03 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Sale | −58,369 | $33.65 | $2.0M | 13,383 |
| 2024-06-03 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise · Incentive Stock Option (Right to Buy) | −6,289 | 0 | ||
| 2024-06-03 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option exercise · Incentive Stock Option (Right to Buy) | −58,369 | 23,023 | ||
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise | +20,625 | $2.78 | $57K | 20,833 |
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise | +28,469 | $28.00 | $797K | 49,302 |
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Option exercise | +18,375 | $22.48 | $413K | 67,677 |
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Sale | −27,580 | $33.53 | $925K | 40,097 |
| 2024-06-03 | Wright Richard M. SR. VP & CCO | Sale | −19,264 | $33.99 | $655K | 20,833 |
Page 5 of 10 · 182 trades